Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166939 · ClinicalTrials.gov registry record · Phase 4
45th Multicenter Airway Research Collaboration
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 1,860
- Enrollment target
NCT07166939: Recruiting Phase 4 study, sponsored by Massachusetts General Hospital.
NCT07166939 is a Phase 4 study that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 1,860 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166939, a Phase 4 study, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 1,860 participants
- Enrollment target
Study Summary
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Interventions
- DRUG Airsupra
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,860 participants |
| Start Date | 2025-11-07 |
| Est. Completion | 2027-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07166939
The ClinicalTrials.gov registry entry for NCT07166939 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 1,860 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Airsupra is the first listed.
NCT07166939 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07166939 about?
NCT07166939 is a clinical study titled "45th Multicenter Airway Research Collaboration". The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
What is the current status of trial NCT07166939?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 1,860 participants. The study started on 2025-11-07. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07166939?
The interventions under investigation include: Airsupra (DRUG).
Who is sponsoring clinical trial NCT07166939?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.